Edges in Network
| Network | GSE5851_top8000 - GSE5851 - SiGN-BN NNSR |
| Network Description | Phase II exploratory pharmacogenomics study of cetuximab monotherapy in patients with advanced metastatic CRC |
| Node | PADI2 |
| Upstream (Parents) |
|---|
| (<<) S100A10 → PADI2 |
| (<<) GPD1L → PADI2 |
| (<<) ITGA3 → PADI2 |
| (<<) FXYD3 → PADI2 |
| (<<) TSPAN1 → PADI2 |
| Downstream (Children) |
|---|
| PADI2 → MMP24 (>>) |
| PADI2 → TEX13B (>>) |
| PADI2 → SOX15 (>>) |
| PADI2 → SLC6A3 (>>) |
| PADI2 → ACE (>>) |
| PADI2 → KCNA6 (>>) |
| PADI2 → ST6GALNAC2 (>>) |
| PADI2 → NOL12 (>>) |
| PADI2 → REN (>>) |
| PADI2 → RCAN1 (>>) |
| PADI2 → UPK3A (>>) |
| PADI2 → KCNQ2 (>>) |
| PADI2 → BPI (>>) |
| PADI2 → RTN2 (>>) |
